BRAF and cancer: The authors thank Tona Gilmer, Li Liu, and Jingping Wang for testing the sensitivity of selected cancer cell lines to dabrafenib, Stacy Walsh and Kathleen Gallagher for generating the human BRAFV600E and BRAF ortholog cDNA constructs, Bradley Heidrich, Olivia Rossanese, and Jessica Ward for assistance with the in vivo studies, and Tim Hart, Kevin French, Diane Boram, Rosanna Mirabile, Janice Kane, and David Dwyer for their consultative and technical contributions in conducting the investigative rat study.